Novavax is around $11.1 after losing 3.94%

Published: January 25 2023, 19:51 GMT+0

Novavax is around $11.1 after losing 3.94%

As the current session draws to a close, the US biotechnology company is hovering around the $11.1 level after closing yesterday at $11.55 and dropping by 3.94%.

Today's session has around a hour left to run with, Nasdaq slides to 11,300 — a loss of 0.43%. Novavax is down while similar drops are seen throughout the Healthcare sector (down 0.417%).

The US biotechnology company has shed 79.19% over the past six months. So far this year, it has performed better than the Nasdaq by 9.62%. The company's market cap currently stands at $943.12 million with an average daily trading volume of 6.95 million shares. Novavax is forecasted to generate revenues of $586.25 million and EPS of $2.21.

Novavax's stock value drop coincides with Abbott Laboratories is trading around $110.32 (down 1.96%). Amgen is down 1.3% from the beginning of the session and now trades around $256.33. Thermo Fisher Scientific is down to $574.56, losing 1.06%, after ending yesterday at $580.72.